Early Alzheimers Disease (DBCOND0131622)
Identifiers
- Synonyms
- Early Alzheimer´s Disease / Early Alzheimer's Disease
Associated Data
- Indicated Drugs and Targets
- Not Available
- Clinical Trials
Identifier Title Drug(s) Purpose Phase Status NCT04777409 A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus) treatment 3 active_not_recruiting NCT04498650 A Study to Evaluate Safety and Tolerability of Different Doses and Efficacy of PQ912 in Subjects With MCI and Mild AD treatment 2 completed NCT06304883 Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects treatment 3 enrolling_by_invitation NCT06565143 Effect of Transcranial Alternating Current Stimulation(tACS) for Early Alzheimer's Disease No drug interventions basic_science Not Available recruiting NCT04770220 An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects treatment 3 completed NCT04599764 High Definition Transcranial Direct Current Stimulation (HD-tDCS) for Early Alzheimer's Disease No drug interventions basic_science Not Available recruiting NCT05122598 Development and Evaluation of Computerized Olfactory Training Program for Cognitive Decline in Early Alzheimer's Disease No drug interventions prevention 2 unknown_status NCT02859207 A Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects No drug interventions treatment 1 completed NCT05531656 A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease No drug interventions treatment 2 recruiting NCT05161715 Proof-of-concept, Open-label Study in Patients With Early Alzheimer's Disease prevention 2 completed NCT04777396 A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE) treatment 3 active_not_recruiting NCT04693520 Biomarker Effects of ALZ-801 in APOE4 Carriers With Early Alzheimer's Disease treatment 2 active_not_recruiting NCT03887455 A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease treatment 3 active_not_recruiting